Navigation Links
IPC The Hospitalist Company Completes New Jersey Acquisition
Date:9/2/2009

NORTH HOLLYWOOD, Calif., Sept. 2 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that it has acquired Hospital Medicine Associates, P.C. (HMA). Based in Livingston, New Jersey, HMA represents IPC's second practice group in the state, following the recent acquisition of a hospitalist group in nearby Morristown. IPC expects to add approximately 25,000 patient encounters annually from the HMA acquisition.

Adam Singer, M.D., IPC's Chairman and CEO, said, "IPC initially established operations in New Jersey in June of this year and the acquisition of HMA will serve to strengthen our presence in this important market. HMA is a high-quality group of providers with skilled leadership but faced the challenges of a limited business infrastructure. Now HMA can build on our solid business platform to grow its practice and reach its full potential."

Ed Crandell, IPC's Executive Director for the region, commented, "HMA's hospitalists will continue to practice at St. Barnabas Medical Center and also provide coverage at skilled nursing and rehabilitation facilities in the surrounding area. We believe that the additional resources from IPC in areas such as recruitment, technology and quality initiatives will enable HMA to increase service levels in these facilities as well as provide opportunities for expansion to additional sites."

HMA's owner, Jaqueline Holubka M.D., will remain with the group and continue to serve as Practice Group Leader. Dr. Holubka remarked, "I look forward to continuing my career as a hospitalist with the IPC family. I've been very impressed with the quality of IPC's clinical leadership and with the company's constant attention to innovation and support of its practice groups."

About IPC The Hospitalist Company, Inc.

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at www.hospitalist.com.

    Media Contact:                       Investor Contacts:
    Scott Public Relations               The Ruth Group
    Elaine Murphy                        Amy Glynn/Nick Laudico
    818.610.0270                         646.536.7023/7030
    elaine@scottpublicrelations.com      aglynn@theruthgroup.com
                                         nlaudico@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company Reports Second Quarter 2009 Results
2. IPC The Hospitalist Company Acquires Tampa Practice
3. Locum Leaders Taps Hospitalist as Chief Medical Officer; Strengthens Leadership in Hospital Medicine Recruitment and Job Placement
4. IPC The Hospitalist Company, Inc. to Report Second Quarter 2009 Results
5. IPC The Hospitalist Company Expands Coverage in Tucson
6. IPC The Hospitalist Company Inc. CEO, Adam Singer, M.D., Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner in the Greater Los Angeles Area
7. IPC The Hospitalist Company Expands Into New Jersey
8. IPC The Hospitalist Company, Inc. to Present at Jefferies 3rd Annual Healthcare Conference
9. Availability of diagnostic tests drive success in hospitalist-run short-stay units
10. IPC The Hospitalist Company, Inc. to Present at Citis 2009 Healthcare Services Day
11. IPC The Hospitalist Company CEO Adam Singer Named One of 50 Most Powerful Physician Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: